Edwards Lifesciences Fundamental Drivers

Edwards Lifesciences Corporation -- USA Stock  

USD 134.25  0.07  0.0521%

The Drivers Module shows relationships between Edwards Lifesciences's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Edwards Lifesciences Corporation over time as well as its relative position and ranking within its peers. Additionally see Investing Opportunities

Edwards Lifesciences Cash per Share vs. Z Score Fundamental Analysis

Edwards Lifesciences Corporation is rated # 2 in z score category among related companies. It is rated # 4 in cash per share category among related companies fabricating about  0.39  of Cash per Share per Z Score. The ratio of Z Score to Cash per Share for Edwards Lifesciences Corporation is roughly  2.56 
Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in late 1960s at New York University..
Edwards Lifesciences 
Z Score 
 = 
Sum Of  
 
5 Factors 
=
16.2
To calculate Z-Score one would need to know current working capital of the company, its total assets and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1 indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Cash per Share is a ratio of current cash on hands or in the banks of the company to total number of shares outstanding. It is used to determine firm's liquidity and is a good indicator of overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Edwards Lifesciences 
Cash per Share 
 = 
Total Cash 
Average Shares 
=
6.34 times
Companies with high Cash per Share ratio will be considered as attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals

Comparison

Cash per Share Comparison
  Cash per Share 
      Edwards Lifesciences Comparables 
Edwards Lifesciences is rated # 3 in cash per share category among related companies.

Revenue

Edwards Lifesciences Revenue Analysis
Edwards Lifesciences Corporation is rated below average in revenue category among related companies. Market size based on revenue of Healthcare Products industry is currently estimated at about 284.68 Billion. Edwards Lifesciences claims roughly 3.44 Billion in revenue contributing just under 2% to equities under Healthcare Products industry.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Appliances Equipment classification in USA and traded on New York Stock Exchange exchange. more
NameEdwards Lifesciences Corporation
Chairman and CEOMichael MussallemAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
InstrumentUSA Stock Stocks Directory
RegionNorth America
ExchangeNew York Stock Exchange
CIK Number01099800.0
ISINUS28176E1082
CUSIP28176E108
CurrencyUSD - US Dollar
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders